Stay updated with breaking news from Exscientia. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Exscientia plc (NASDAQ:EXAI – Get Free Report) gapped down prior to trading on Wednesday after Bank of America lowered their price target on the stock from $16.00 to $11.00. The stock had previously closed at $4.59, but opened at $4.49. Exscientia shares last traded at $4.48, with a volume of 38,376 shares trading hands. Several […]
Specific targets were not disclosed, but Merck KGaA is betting the artificial intelligence technologies of Exscientia and BenevolentAI will discover into new drugs for cancer, neurology, and immunology.
Shares of Exscientia plc (NASDAQ:EXAI – Get Free Report) shot up 3.5% during mid-day trading on Monday . The company traded as high as $5.32 and last traded at $5.32. 21,115 shares traded hands during trading, a decline of 94% from the average session volume of 339,252 shares. The stock had previously closed at $5.14. […]
Exscientia (NASDAQ:EXAI – Get Free Report) and Omega Therapeutics (NASDAQ:OMGA – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, risk, earnings, institutional ownership, valuation, dividends and profitability. Analyst Ratings This is a summary of current […]
Exscientia (NASDAQ:EXAI – Get Free Report) and Repligen (NASDAQ:RGEN – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, dividends, profitability, analyst recommendations, valuation, risk and institutional ownership. Analyst Recommendations This is a summary of recent recommendations and […]